Fig. 4From: The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysisSignificant difference (p 0.0023) in the survival curves of patients who underwent autologous hematopoietic stem cell transplant (AHSCT) and those who did not (A). Significant (p 0.0167) differences noted in the survival curves of patients aged above and up to 65 years of age, as per them having undergone AHSCT or not (B)Back to article page